AS

Aajan Sowthama

Active Director Director DIN 09857151
DIN 09857151 First appointment Jan 2023 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jan 2023
Shareholding value Locked Premium profile

About Aajan Sowthama

Aajan Sowthama has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Meds Ease Foundation. Engaged in General Business. Contributes to corporate operations.

DIN 09857151
Primary Designation Director
First Appointment 10 Jan 2023
Oldest Company Age 3 yrs

Current companies

Company Designation Appointment Founded Status
Meds Ease Foundation U85320TZ2023NPL040786
Director 10 Jan 2023 2023 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Meds Ease Foundation
Premium access

Shareholding and investment profile for Aajan Sowthama

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aajan Sowthama

Aajan Sowthama has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Meds Ease Foundation. Engaged in General Business. Contributes to corporate operations.

Aajan Sowthama is associated with 1 company as Director.

Aajan Sowthama has expertise in General Business.

Aajan Sowthama has 3 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available